Russell Investments Group
LYRA

Russell Investments Group’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Russell Investments Group’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,594
Closed -$14.3K – 4195
2025
Q2 		$14.3K Buy
+1,594
New +$13.2K ﹤0.01% 3260
2020
Q4 		– Sell
-274
Closed -$153K – 3131
2020
Q3 		$153K Buy
+274
New +$170K ﹤0.01% 2878

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Russell Investments Group's LYRA Position: Q3 2025 in Review

Russell Investments Group sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2025, closing a stake of 1,594 shares — an estimated $14.3K sold.

Russell Investments Group first reported a position in LYRA in Q3 2020 and held it in 2 quarters. The position peaked at $153K in Q3 2020. 26 funds tracked by Wall St. Rank hold LYRA as of Q3 2025.

  • Russell Investments Group reported no remaining LYRA THERAPEUTICS INC position as of Q3 2025 after selling out during the quarter.
  • Russell Investments Group sold 1,594 LYRA THERAPEUTICS INC shares in Q3 2025, an estimated $14.3K.
  • Russell Investments Group first reported a position in LYRA THERAPEUTICS INC in Q3 2020 and held it in 2 quarters.
  • Russell Investments Group's LYRA THERAPEUTICS INC position peaked at $153K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2025.

Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.